Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Construction of poliovirus intertypic recombinants by use of cDNA.

Literature DB >> 3005620

Construction of poliovirus intertypic recombinants by use of cDNA.

G Stanway, P J Hughes, G D Westrop, D M Evans, G Dunn, P D Minor, G C Schild, J W Almond.

Abstract

We investigated the use of infectious cDNA for the production of poliovirus type 1-type 3 recombinants. One such recombinant virus was produced, but a second construct involving the transfer of part of the capsid protein region was not infectious. Our results suggest that the approach may prove valuable but that not all cDNA constructs will give rise to viable viruses.

Entities: Species

Mesh：

Substances：

Year: 1986 PMID： 3005620 PMCID： PMC252858

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

21 in total

1. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.

Authors: P D Minor; D M Evans; M Ferguson; G C Schild; G Westrop; J W Almond
Journal: J Gen Virol Date: 1985-05 Impact factor: 3.891

2. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain.

Authors: M Kohara; T Omata; A Kameda; B L Semler; H Itoh; E Wimmer; A Nomoto
Journal: J Virol Date: 1985-03 Impact factor: 5.103

3. Neurovirulence of the intertypic poliovirus recombinant v3/a1-25: characterization of strains isolated from the spinal cord of diseased monkeys and evaluation of the contribution of the 3' half of the genome.

Authors: V I Agol; S G Drozdov; M P Frolova; V P Grachev; M S Kolesnikova; V G Kozlov; N M Ralph; L I Romanova; E A Tolskaya; E G Viktorova
Journal: J Gen Virol Date: 1985-02 Impact factor: 3.891

4. The complete nucleotide sequence of a common cold virus: human rhinovirus 14.

Authors: G Stanway; P J Hughes; R C Mountford; P D Minor; J W Almond
Journal: Nucleic Acids Res Date: 1984-10-25 Impact factor: 16.971

5. Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: biochemical and biological properties of the recovered virus.

Authors: T Omata; M Kohara; Y Sakai; A Kameda; N Imura; A Nomoto
Journal: Gene Date: 1984-12 Impact factor: 3.688

6. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine.

Authors: A J Cann; G Stanway; P J Hughes; P D Minor; D M Evans; G C Schild; J W Almond
Journal: Nucleic Acids Res Date: 1984-10-25 Impact factor: 16.971

7. Cloned poliovirus complementary DNA is infectious in mammalian cells.

Authors: V R Racaniello; D Baltimore
Journal: Science Date: 1981-11-20 Impact factor: 47.728

Review 8. Picornaviral structure and assembly.

Authors: J R Putnak; B A Phillips
Journal: Microbiol Rev Date: 1981-06

9. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome.

Authors: D M Evans; G Dunn; P D Minor; G C Schild; A J Cann; G Stanway; J W Almond; K Currey; J V Maizel
Journal: Nature Date: 1985 Apr 11-17 Impact factor: 49.962

10. Regulation of simian virus 40 transcription: sensitive analysis of the RNA species present early in infections by virus or viral DNA.

Authors: B A Parker; G R Stark
Journal: J Virol Date: 1979-08 Impact factor: 5.103

13 in total

1. Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.

Authors: Javier Martín; Elena Samoilovich; Glynis Dunn; Angie Lackenby; Esphir Feldman; Alan Heath; Ekaterina Svirchevskaya; Gill Cooper; Marina Yermalovich; Philip D Minor
Journal: J Virol Date: 2002-11 Impact factor: 5.103

2. Genetic variation occurring on the genome of an in vitro insertion mutant of poliovirus type 1.

Authors: S Kuge; N Kawamura; A Nomoto
Journal: J Virol Date: 1989-03 Impact factor: 5.103

3. Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication.

Authors: S Kuge; A Nomoto
Journal: J Virol Date: 1987-05 Impact factor: 5.103

4. Mapping of the fibrotropic and lymphotropic host range determinants of the parvovirus minute virus of mice.

Authors: E M Gardiner; P Tattersall
Journal: J Virol Date: 1988-08 Impact factor: 5.103

5. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.

Authors: M Kohara; S Abe; T Komatsu; K Tago; M Arita; A Nomoto
Journal: J Virol Date: 1988-08 Impact factor: 5.103

6. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus.

Authors: A McGoldrick; A J Macadam; G Dunn; A Rowe; J Burlison; P D Minor; J Meredith; D J Evans; J W Almond
Journal: J Virol Date: 1995-12 Impact factor: 5.103

7. Production of guanidine-resistant and -dependent poliovirus mutants from cloned cDNA: mutations in polypeptide 2C are directly responsible for altered guanidine sensitivity.

Authors: S E Pincus; E Wimmer
Journal: J Virol Date: 1986-11 Impact factor: 5.103